Results 61 to 70 of about 573,740 (334)

A collaborative care pathway for patients with suspected angle closure glaucoma spectrum disease

open access: yesClinical and experimental optometry, 2020
Currently, no specific collaborative care pathway exists that distinguishes open angle glaucoma from narrow angle or angle closure disease. This study evaluates a newly developed referral and collaborative care pathway specifically for patients with ...
Jack Phu   +4 more
semanticscholar   +1 more source

The complexity of dementia development and its comorbidities: The collaborative cross‐mouse population for multivarious tasks approach

open access: yesAnimal Models and Experimental Medicine, EarlyView.
The increasing prevalence of dementia and related neurodegenerative diseases—including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and amyotrophic lateral sclerosis—poses a growing public health challenge. These conditions have traditionally been studied as isolated central nervous system disorders, but emerging evidence points to ...
Osayd Zohud   +3 more
wiley   +1 more source

Profile of the subtypes of angle closure glaucoma in a tertiary hospital in North India

open access: yesIndian Journal of Ophthalmology, 1998
A prospective study of 500 consecutive patients of primary angle closure glaucoma was undertaken to study the clinical profile of the three subtypes: acute, subacute, and chronic.
Sihota Ramanjit, Agarwal H
doaj  

MISTAKES IN THE DIAGNOSIS AND TREATMENT OF PRIMARY ANGLE-CLOSURE GLAUCOMA: CASE REPORT

open access: yesSanamed, 2016
Primary angle-closure glaucoma (PACG) is a leading cause of blindness globally. It is a condition that is responsible for nearly half of patients who have a bilateral blindness caused by glaucoma.
Marić Vesna   +3 more
doaj   +1 more source

Severity of Visual Field Loss at First Presentation to Glaucoma Clinics in England and Tanzania [PDF]

open access: yes, 2019
Purpose: To compare severity of visual field (VF) loss at first presentation in glaucoma clinics in England and Tanzania. Methods: Large archives of VF records from automated perimetry were used to retrospectively examine vision loss at first ...
Adegbehingbe BO   +9 more
core   +3 more sources

Cannabinoids and drug–drug pharmacokinetic interactions: Deciphering the risks

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
The relationship between cannabinoids and mental health has become a major focus of scientific inquiry and public discourse. Cannabinoids are diverse chemical compounds from the Cannabis species that have been explored for their therapeutic applications in treating chronic pain, psychiatric and neurological conditions, such as depression, schizophrenia,
Paraskevi Papakyriakopoulou   +2 more
wiley   +1 more source

Treat the individual and not the angle

open access: yesIndian Journal of Ophthalmology
Background: Glaucoma, the silent thief of sight, is one of the most common vision-threatening conditions. Even though POAG (primary open angle glaucoma) is more common, PACG (primary angle closure glaucoma) is the dreaded variant.
Saloni M Joshi   +4 more
doaj   +1 more source

Retinal Nerve Fiber Layer and Macula Ganglion Cell Thickness in Eyes with Primary Angle Closure [PDF]

open access: yes, 2017
Decreased thickness of retina nerve fiber layer (RNFL) and ganglion cells of inner plexifom layer (GLIPL) in patients with glaucoma suspect can represent early detection of retina nerve defect.
Artini, W. (Widya)
core   +2 more sources

Anterior Segment Features in Nanophthalmos With Secondary Chronic Angle Closure Glaucoma: An Ultrasound Biomicroscopy Study.

open access: yesInvestigative Ophthalmology and Visual Science, 2019
Purpose We compare anterior segment parameters and the risk of malignant glaucoma between nanophthalmos with secondary chronic angle closure glaucoma (NSCACG) and chronic primary angle-closure glaucoma (CPACG).
Congcong Guo   +9 more
semanticscholar   +1 more source

Nanostructured drug delivery systems for posterior segment eye diseases: Strategies to defy ocular barriers

open access: yesBMEMat, EarlyView.
Efficient drug delivery to the posterior segment of the eye has long been a challenging issue due to the complex ocular barriers. The review focuses on the promise held by nanoplatforms for barrier penetration and the key mechanisms involved, also highlighting their advantages in achieving efficient drug delivery and superior treatment of PSEDs ...
Yifan Shen   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy